Methods of treating inflammatory bowel disease using cholera toxin B subunit |
| What is claimed is: 1. A method of treating inflammatory bowel disease in a subject diagnosed with ... |
|
Anti hepatitis C virus antibody and uses thereof |
| OF THE PRESENT INVENTION Accordingly, the technical problem of the invention is to provide means ... |
|
Chemical and/or biological decontamination system |
| OF THE INVENTION The present invention provides a composition that is effective in the ... |
|
Immunostimulant bacterial membrane fractions in cancer treatment |
| The invention claimed is: 1. A method of stimulating an immune response and/or inducing an ... |
|
Cloning and characterization of a human adenylyl cyclase |
| One aspect of the invention is an isolated and purified human type VI adenylyl cyclase (hAC6) ... |
|
Tumor antigen based on products of the tumor suppressor gene WT1 |
| What is claimed is: 1. An isolated polypeptide which consists of at most 12 contiguous amino acid ... |
|
Methods of inhibiting GPR-9-6 function |
| The invention relates to an antibody (immunoglobulin) or functional fragment thereof (e.g., an ... |
|
Method for cloning of a rare, specifically mutated cell |
| The invention is a new and improved method for reliably detecting the presence of a rare cell ... |
|
Vaccine against Gram-negative bacterial infections |
| OF THE PREFERRED EMBODIMENTS According to the present invention, a non-covalent, polyvalent ... |
|
|
Large DNA cloning system based on yeast artificial chromosomes
| Details |
Inventors: Olson, Maynard V.; Burke, David T.;
Assignee: Washington University (St. Louis, MO)
Primary Examiner: Teskin; Robin
Assistant Examiner:
Attorney, Agent or Firm: Meyer; Scott J., Williams, Jr.; James W.
A large DNA cloning system is disclosed which is based on yeast artificial chromosomes. Cloning vectors are disclosed which allow the cloning of large segments of greater than 50 kb of exogenous DNA. The cloning vector comprises DNA sequences of an autonomous replication sequence, a centromere, a selectable yeast marker, two sequences that seed telomere function in vivo, and a cloning site within an interruptible yeast gene for insertion of the exogenous DNA segments. |
|
DETAILED DESCRIPTION OF THE INVENTION While the specification concludes with claims particularly pointing out and distinctly claiming the subject matter regarded as forming the present invention, it is believed that the invention will be better understood from the following description of preferred embodiments taken in connection with the accompanying drawings in which briefly: FIG. 1 is a diagrammatic representation which shows the yeast plasmid vector pYAC2 and its use in the construction of a linear yeast artificial chromosome (YAC) in one embodiment of the invention. FIG. 2 shows the results of electrophoresis of 5 YAC clones derived from the pYAC2 plasmid of FIG. 1. FIG. 3 shows the results of electrophoresis of a YAC human/yeast clone HY1 of FIG. 2, using the yeast host strain AB1380, demonstrating that the DNA insert is a single large Sma I fragment. FIG. 4 shows the results of electrophoresis of a YAC yeast/yeast clone YY1 of FIG. 2 demonstrating that the large yeast Sma I fragment of the clone is also present in the genome of the source yeast. FIG. 5 shows the results of electrophoresis demonstrating the indirect-end-label mapping of the clone of FIG. 4 with BamH I. FIG. 6 is a diagrammatic representation which shows the yeast plasmid vector pYAC4 in another embodiment of the invention. FIG. 7 shows the results of electrophoresis demonstrating the sizing of yeast artificial chromosomes present in ten transformants generated by cloning human DNA fragments into the yeast plasmid vector pYAC4 of FIG. 6. Plasmids pYAC2 and pYAC4 are on deposit without restriction at the American Type Culture Collection, Rockville, Md. , under accession numbers ATCC 67380 and ATCC 67379, respectively. Saccharomyces cerevisiae strain AB1380 is similarly on deposit without restriction at said depository under accession number ATCC 20843. The preferred embodiments of the invention described herein employ the use of a number of commonly available restriction endonucleases which are identified below with their corresponding recognition sequences and (indicated by arrow) cleavage patterns
|
| Related patents |
|
|
Rat neurotrophic factor receptor, GFRα-4
OF THE INVENTION Thus, the present invention relates to a nucleic acid molecule encoding a mammalian GDNF family receptor α-4 (GFRα-4) or an immunologically ...
|
|
|
Polypeptide and protein derivatives and process for their preparation
What we claim is: 1. A method of producing a composition containing modified protein or polypeptide molecules, or salts thereof, wherein said modified protein or ...
|
|
|
Single chain MHC complexes and uses thereof
The present invention relates to novel complexes of major histocompability complex (MHC) molecules (class I or II), e.g., empty single chain MHC class II complexes, ...
|
|
|
IL-1/TNF-.alpha.-activated kinase (ITAK), and methods of making and using the same
The present invention provides nucleic acid and amino acid sequences of protein kinases, preferably human, that interact with at least one post-receptor intracellular ...
|
|
|
DNA encoding IL-1 receptor accessory protein
What is claimed is: 1. An isolated polynucleotide comprising SEQ ID NO:1 wherein the nucleic acid at 1792 is A or C. 2. An isolated polynucleotide comprising a nucleic ...
|
|
|
Human immunodeficiency virus immunogenic composition
The present invention relates to an HLA-based vaccine against HIV. Vaccines of the invention, which induce salutary anti-HIV immune responses, can be designed based on ...
|
|
|
Recombinant molecule encoding human protease nexin
We claim: 1. An isolated DNA molecule which encodes mature protease nexin-I (PN-I) alpha of FIG. 3 or PN-I beta of FIG. 4 or encodes a PN-I protein encoded by a gene ...
|
|
|
Method for design of substances that enhance memory and improve the quality of life
I claim: 1. Each of the compounds Gln Phe Phe-.gamma.-aminobutyric acid (SEQ ID NO: 20) Gln Phe Phe-.beta.-alanine (SEQ ID NO: 21) Gln Phe Phe-.delta.-aminovaleric acid (...
|
|
|
Amyloid .beta. protein (globular assembly and uses thereof)
What is claimed is: 1. An isolated, soluble, non-fibrillar amyloid .beta. protein assembly comprising 3-12 amyloid .beta. proteins, wherein the amyloid .beta. protein is ...
|
|
|
Chlamydia antigens and corresponding DNA fragments and uses thereof
The present invention provides purified and isolated polynucleotide molecules that encode the Chlamydia polypeptide designated 76 kDa protein (SEQ ID No: 1) which can be ...
|
|
|